GILD’s 4Q14 HCV sales: http://finance.yahoo.com/news/gilead-sciences-announces-fourth-quarter-210500475.html Harvoni $2.11B (95% US) Sovaldi $1.73B (68% US) === Total HCV sales $3.84B (83% US)